|
Re: Finance
|
2
|
Resverlogix Corp.
|
May 26, 2020 06:13PM
|
|
Re: Finance
|
4
|
Resverlogix Corp.
|
Apr 13, 2021 10:54AM
|
|
Re: Exempt Distribution- 2021-04-12
|
8
|
Resverlogix Corp.
|
Apr 14, 2021 01:09PM
|
|
Re: Don's April 14th Interview on the Drive
|
6
|
Resverlogix Corp.
|
Apr 15, 2021 04:08PM
|
|
Re: Cytokine storm hypothesis takes a hit with the latest IL-6 targeted therapies
|
5
|
Resverlogix Corp.
|
May 06, 2020 09:17PM
|
|
Re: Cytokine storm hypothesis takes a hit with the latest IL-6 targeted therapies
|
3
|
Resverlogix Corp.
|
Apr 27, 2020 01:10PM
|
|
Re: Cytokine storm hypothesis takes a hit with the latest IL-6 targeted therapies
|
12
|
Resverlogix Corp.
|
Apr 27, 2020 02:39PM
|
|
Re: cut to the chase
|
7
|
Resverlogix Corp.
|
Jun 10, 2020 12:28PM
|
|
Re: COVID trial now in CTD
|
3
|
Resverlogix Corp.
|
May 15, 2021 12:23PM
|
|
Re: COVID 19 - Standard of Care
|
5
|
Resverlogix Corp.
|
Apr 22, 2021 08:55AM
|
|
Re: Canaccord (#33) dumping stock
|
5
|
Resverlogix Corp.
|
May 26, 2020 01:39PM
|
|
Re: Breakthrough Designation
|
10
|
Resverlogix Corp.
|
May 28, 2020 07:36AM
|
|
Re: BOOM there it is
|
7
|
Resverlogix Corp.
|
Apr 07, 2021 07:08PM
|
|
Re: Bioasis Announces Publication of CNS Delivery of siRNA via xB³ ™ Platform Technology
|
1
|
BIOASIS TECHNOLOGIES INC
|
Mar 29, 2021 04:19PM
|
|
Re: BETonMACE paper just published
|
3
|
Resverlogix Corp.
|
Mar 27, 2020 01:13PM
|
|
Re: BETonMACE paper just published
|
4
|
Resverlogix Corp.
|
Mar 27, 2020 03:12PM
|
|
Re: BETonMACE Cognition Sub-Study Published
|
7
|
Resverlogix Corp.
|
Sep 01, 2021 12:36PM
|
|
Re: BETOnMACE CHF and eGFR
|
4
|
Resverlogix Corp.
|
Mar 28, 2020 07:36PM
|
|
Re: Bear - KOO
|
5
|
Resverlogix Corp.
|
Jun 06, 2020 12:04PM
|
|
Re: Apabetalone’s Positive Effect on Hospitalized Patients Involving HF - simple suggestion
|
5
|
Resverlogix Corp.
|
Jan 13, 2021 03:47PM
|
